BLT2 antagonist-1
BLT2 antagonist-1 (compound 15b) is a selective BLT2 antagonist that inhibits the chemotaxis of CHO-BLT2 cells with an IC50 of 224 nM. BLT2 antagonist-1 does not inhibits the chemotaxis of CHO-BLT1 cells. BLT2 antagonist-1 also inhibits the binding of LTB4 and BLT2 with a Ki value of 132 nM. BLT2 antagonist-1 can be used for the research of the inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease[1].
Product Specifications
CAS Number
2069220-61-5
UNSPSC
12352005
Target
Leukotriene Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/blt2-antagonist-1.html
Solubility
10 mM in DMSO
Smiles
O=C(CCCC)N(C1=CC=CC(F)=C1)CC2=CC=C(C3=CC=C(OCC(O)=O)C=C3)C=C2
Molecular Formula
C26H26FNO4
Molecular Weight
435.49
References & Citations
[1]Hyejun Park, et al. Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases. Eur J Med Chem. 2023 Oct 7:261:115864.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LTB4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![HIV1 p24 Mouse monoclonal Antibody [12G4]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea813ff/imageurl/ha600010-50ul.webp)
![CD47 Mouse Monoclonal Antibody [Clone ID: OTI6B2]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908f47/imageurl/cf813324.webp)
